reference/20208816

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/20208816

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
endingPage	13657
issn	1949-2553
issueIdentifier	15
pageRange	13644-13657
publicationName	Oncotarget
startingPage	13644
bibliographicCitation	Vieira FQ, Costa-Pinheiro P, Almeida-Rios D, Graça I, Monteiro-Reis S, Simões-Sousa S, Carneiro I, Sousa EJ, Godinho MI, Baltazar F, Henrique R, Jerónimo C. SMYD3 contributes to a more aggressive phenotype of prostate cancer and targets Cyclin D2 through H4K20me3. Oncotarget. 2015 May 30;6(15):13644–57. PMID: 25980436; PMCID: PMC4537039.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c08820aefb25704eea0323ad90d22499 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4daac4a025614a150ae5f1e041c65a45 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_405560c374a2047421b17bd151daf5e4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9e0cec47d9f918cbe45e5530620d35fc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1f98d5ad86d55189e0d9cd1e8a36fef6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ce2a9de7cb8506ce6a64469f3da65375 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dff20e3a009176b7ba837c23d6a6076a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_648290312cd6f87e37df673b4eca1c93 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dd88447e9ede3b1e553fe2212c88132c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1e199dab20f02833ee8abcf764be37bb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f3f682eedaf987122b07bf72323994fe http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a1d0d746b68ce0654bb31c6701a24d36
date	2015-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC4537039 https://pubmed.ncbi.nlm.nih.gov/25980436 https://doi.org/10.18632/oncotarget.3767
isPartOf	https://portal.issn.org/resource/ISSN/1949-2553 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/37803
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	SMYD3 contributes to a more aggressive phenotype of prostate cancer and targets Cyclin D2 through H4K20me3
discusses	http://id.nlm.nih.gov/mesh/M0017870 http://id.nlm.nih.gov/mesh/M0214665 http://id.nlm.nih.gov/mesh/M0493027 http://id.nlm.nih.gov/mesh/M0528978
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D011495Q000378 http://id.nlm.nih.gov/mesh/D011471Q000473 http://id.nlm.nih.gov/mesh/D056742Q000378
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D055785 http://id.nlm.nih.gov/mesh/D011495Q000235 http://id.nlm.nih.gov/mesh/D011471Q000201 http://id.nlm.nih.gov/mesh/D002470Q000502 http://id.nlm.nih.gov/mesh/D010641 http://id.nlm.nih.gov/mesh/D002642 http://id.nlm.nih.gov/mesh/D045744 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D011471Q000235 http://id.nlm.nih.gov/mesh/D011471Q000378 http://id.nlm.nih.gov/mesh/D056742Q000235 http://id.nlm.nih.gov/mesh/D002465Q000502 http://id.nlm.nih.gov/mesh/D049109Q000502 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000818
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8983 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11431 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7025 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_3d27164b3dd1f5e2a82ec19dc6496211 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_499cf234c67a94675527addd716e08b4 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_e4aea554321003fde714f5d9131725e6

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID894 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID64754

Total number of triples: 61.